BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 27091627)

  • 1. The Molecular Registry of Pituitary Adenomas (REMAH): A bet of Spanish Endocrinology for the future of individualized medicine and translational research.
    Luque RM; Ibáñez-Costa A; Sánchez-Tejada L; Rivero-Cortés E; Robledo M; Madrazo-Atutxa A; Mora M; Álvarez CV; Lucas-Morante T; Álvarez-Escolá C; Fajardo C; Castaño L; Gaztambide S; Venegas-Moreno E; Soto-Moreno A; Gálvez MÁ; Salvador J; Valassi E; Webb SM; Picó A; Puig-Domingo M; Gilabert M; Bernabéu I; Marazuela M; Leal-Cerro A; Castaño JP;
    Endocrinol Nutr; 2016; 63(6):274-84. PubMed ID: 27091627
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pituitary tumor transforming gene and insulin-like growth factor 1 receptor expression and immunohistochemical measurement of Ki-67 as potential prognostic markers of pituitary tumors aggressiveness.
    Sánchez-Tejada L; Sánchez-Ortiga R; Moreno-Pérez O; Montañana CF; Niveiro M; Tritos NA; Alfonso AM
    Endocrinol Nutr; 2013; 60(7):358-67. PubMed ID: 23416216
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular classification of pituitary adenomas: in search for criteria useful for high-throughput studies.
    Żebracka-Gala J; Rudnik A; Hasse-Lazar K; Larysz D; Jarząb M; Krajewska J; Bażowski P; Jarząb B
    Endokrynol Pol; 2016; 67(2):148-56. PubMed ID: 26884293
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pituitary hormone mRNA in null cell adenomas and oncocytomas by in situ hybridization comparison with immunohistochemical and clinical data.
    Schmid M; Münscher A; Saeger W; Schreiber S; Lüdecke DK
    Pathol Res Pract; 2001; 197(10):663-9. PubMed ID: 11700887
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pathohistological classification of pituitary tumors: 10 years of experience with the German Pituitary Tumor Registry.
    Saeger W; Lüdecke DK; Buchfelder M; Fahlbusch R; Quabbe HJ; Petersenn S
    Eur J Endocrinol; 2007 Feb; 156(2):203-16. PubMed ID: 17287410
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Integrative clinical, hormonal, and molecular data associate with invasiveness in acromegaly: REMAH study.
    Sampedro-Nuñez M; Herrera-Martínez AD; Ibáñez-Costa A; Rivero-Cortés E; Venegas E; Robledo M; Martínez-Hernández R; García-Martínez A; Gil J; Jordà M; López-Fernández J; Gavilán I; Maraver S; Marqués-Pamies M; Cámara R; Fajardo-Montañana C; Valassi E; Dios E; Aulinas A; Biagetti B; Álvarez Escola C; Araujo-Castro M; Blanco C; Paz M; Villar-Taibo R; Álvarez CV; Gaztambide S; Webb SM; Castaño L; Bernabéu I; Picó A; Gálvez MÁ; Soto-Moreno A; Puig-Domingo M; Castaño JP; Marazuela M; Luque RM;
    Eur J Endocrinol; 2024 Jun; 190(6):421-433. PubMed ID: 38701338
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of E-cadherin, Slug and NCAM and its relationship to tumor invasiveness in patients with acromegaly.
    Mendes GA; Haag T; Trott G; Rech CGSL; Ferreira NP; Oliveira MC; Kohek MB; Pereira-Lima JFS
    Braz J Med Biol Res; 2017 Dec; 51(2):e6808. PubMed ID: 29267504
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Immunohistochemistry for pituitary hormones and Ki-67 in growth hormone producing pituitary adenomas].
    Brito J; Sáez L; Lemp M; Liberman C; Michelsen H; Araya AV
    Rev Med Chil; 2008 Jul; 136(7):831-6. PubMed ID: 18949157
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of the growth hormone secretagogue receptor in pituitary adenomas and other neuroendocrine tumors.
    Korbonits M; Jacobs RA; Aylwin SJ; Burrin JM; Dahia PL; Monson JP; Honegger J; Fahlbush R; Trainer PJ; Chew SL; Besser GM; Grossman AB
    J Clin Endocrinol Metab; 1998 Oct; 83(10):3624-30. PubMed ID: 9768675
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glycoprotein hormone genes are expressed in clinically nonfunctioning pituitary adenomas.
    Jameson JL; Klibanski A; Black PM; Zervas NT; Lindell CM; Hsu DW; Ridgway EC; Habener JF
    J Clin Invest; 1987 Nov; 80(5):1472-8. PubMed ID: 2824561
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of somatostatin receptors on human pituitary adenomas in vivo and ex vivo.
    Nielsen S; Mellemkjaer S; Rasmussen LM; Ledet T; Olsen N; Bojsen-Møller M; Astrup J; Weeke J; Jørgensen JO
    J Endocrinol Invest; 2001 Jun; 24(6):430-7. PubMed ID: 11434667
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparison between the diagnostic value of gonadotropins, alpha-subunit, and chromogranin-A and their response to thyrotropin-releasing hormone in clinically nonfunctioning, alpha-subunit-secreting, and gonadotroph pituitary adenomas.
    Nobels FR; Kwekkeboom DJ; Coopmans W; Hoekstra R; De Herder WW; Bouillon R; Lamberts SW
    J Clin Endocrinol Metab; 1993 Sep; 77(3):784-9. PubMed ID: 7690365
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Treatment of pituitary adenomas].
    Mezosi E; Nemes O
    Orv Hetil; 2009 Sep; 150(39):1803-10. PubMed ID: 19758960
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of interleukin-6, interleukin-6 receptor (gp80), and the receptor's signal-transducing subunit (gp130) in human normal pituitary glands and pituitary adenomas.
    Kurotani R; Yasuda M; Oyama K; Egashira N; Sugaya M; Teramoto A; Osamura RY
    Mod Pathol; 2001 Aug; 14(8):791-7. PubMed ID: 11504839
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinicopathological characteristics and therapeutic outcomes in thyrotropin-secreting pituitary adenomas: a single-center study of 90 cases.
    Yamada S; Fukuhara N; Horiguchi K; Yamaguchi-Okada M; Nishioka H; Takeshita A; Takeuchi Y; Ito J; Inoshita N
    J Neurosurg; 2014 Dec; 121(6):1462-73. PubMed ID: 25237847
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incidence and familial risks in pituitary adenoma and associated tumors.
    Hemminki K; Försti A; Ji J
    Endocr Relat Cancer; 2007 Mar; 14(1):103-9. PubMed ID: 17395979
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnosis and treatment of pituitary adenomas.
    Chanson P; Salenave S
    Minerva Endocrinol; 2004 Dec; 29(4):241-75. PubMed ID: 15765032
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Very low frequency of germline GPR101 genetic variation and no biallelic defects with AIP in a large cohort of patients with sporadic pituitary adenomas.
    Lecoq AL; Bouligand J; Hage M; Cazabat L; Salenave S; Linglart A; Young J; Guiochon-Mantel A; Chanson P; Kamenický P
    Eur J Endocrinol; 2016 Apr; 174(4):523-30. PubMed ID: 26792934
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genomic and molecular characterization of pituitary adenoma pathogenesis: review and translational opportunities.
    Elsarrag M; Patel PD; Chatrath A; Taylor D; Jane JA
    Neurosurg Focus; 2020 Jun; 48(6):E11. PubMed ID: 32480367
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of hypophysiotropic factors on growth hormone and prolactin secretion from somatotroph adenomas in culture.
    Ishibashi M; Yamaji T
    J Clin Endocrinol Metab; 1985 May; 60(5):985-93. PubMed ID: 2858494
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.